skip to Main Content

The Challenges of Purifying Conjugate Vaccines and Vaccine Components

Andrew Lees, Fina Biosolutions’ scientific director, speaks on the challenges of purifying conjugate vaccines and vaccine components.

Ion Exchange: Pore choices and ion clouds: aspects of resin architecture that affect chromatography

Andrew Lees, Ph.D., Scientific Director, Fina Biosolutions LLCRockville, MD 

Please enter your details to download the PDF